力诺药包(301188.SZ)发布前三季度业绩，归母净利润5088.23万元，下降27.80%

Core Viewpoint - Linuo Pharmaceutical (301188.SZ) reported a decline in revenue and net profit for the first three quarters of 2025, indicating potential challenges in its financial performance [1] Financial Performance - The company's operating revenue for the first three quarters was 721 million yuan, a year-on-year decrease of 13.22% [1] - The net profit attributable to shareholders was 50.88 million yuan, reflecting a year-on-year decrease of 27.80% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 35.58 million yuan, down 43.60% year-on-year [1] - Basic earnings per share stood at 0.22 yuan [1]